Skip to main content

IR-Med, Inc. (IRME) Stock Forecast 2025 - AI Price Prediction & Analysis


IR-Med, Inc. (IRME) AI Stock Price Forecast & Investment Analysis

IR-Med, Inc. Stock Price Chart and Technical Analysis

Loading IR-Med, Inc. interactive price chart and technical analysis...

IR-Med, Inc. (IRME) - Comprehensive Stock Analysis & Investment Research

Deep dive into IR-Med, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about IR-Med, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For IR-Med, Inc.: IR-Med, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

IR-Med, Inc. (Stock Symbol: IRME) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing IR-Med, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For IR-Med, Inc.:

Market Capitalization: $2 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for IR-Med, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For IR-Med, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for IR-Med, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: IR-Med, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For IR-Med, Inc.: Market positioning analysis based on available financial and operational metrics.

IR-Med, Inc. strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

IR-Med, Inc. (IRME) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for IR-Med, Inc. stock analysis.

Loading IR-Med, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into IR-Med, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if IR-Med, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For IR-Med, Inc.:

Market Cap $2M
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently IR-Med, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For IR-Med, Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess IR-Med, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For IR-Med, Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal IR-Med, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For IR-Med, Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively IR-Med, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For IR-Med, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from IR-Med, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For IR-Med, Inc.:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 77M

Latest IR-Med, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting IR-Med, Inc. (IRME) stock price and investment outlook.

, source: Yahoo Finance

Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial intelligence (AI)-powered spectrographic ...

, source: The Globe and Mail

Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by Bay Street pros, advisors and Canadians who invest on their own, they help ...

, source: Seeking Alpha

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a ...

, source: The Globe and Mail

The latest announcement is out from IR-Med ( (IRME)). IR-Med, Inc. and Williamsburg Venture Holdings, LLC entered into an Equity Purchase Agreement on March 11, 2025, for an investment of up to $15 ...

, source: Business Wire

ROSH PINNA, Israel--(BUSINESS WIRE)--IR-Med (“IR-MED or the “Company”) (OTCQB:IRME), an innovative development-stage medical device company utilizing Infra-Red light spectroscopy (IR) and Artificial ...

IR-Med, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of IR-Med, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $759M -41.7x 6.8x
CBLL Unlock Forecast - 30 Days FREE Trial $465M x 2.7x
CNMD Unlock Forecast - 30 Days FREE Trial $1398M 12.7x 1.4x
CV Unlock Forecast - 30 Days FREE Trial $12M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.9x
EDAP Unlock Forecast - 30 Days FREE Trial $84M x 2.1x
ELMD Unlock Forecast - 30 Days FREE Trial $203M 26.9x 4.7x
FONR Unlock Forecast - 30 Days FREE Trial $103M 9.9x 0.7x
GTHP Unlock Forecast - 30 Days FREE Trial $18M x x
INMD Unlock Forecast - 30 Days FREE Trial $1055M x 1.5x
IRIX Unlock Forecast - 30 Days FREE Trial $17M -2.8x 2.9x
IRME Unlock Forecast - 30 Days FREE Trial $2M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3613M 43.7x 2.1x
LIVN Unlock Forecast - 30 Days FREE Trial $2938M -662.0x 2.6x
MASI Unlock Forecast - 30 Days FREE Trial $7994M 128.1x 7.7x
MDT Unlock Forecast - 30 Days FREE Trial $122777M 26.4x 2.6x
NRXS Unlock Forecast - 30 Days FREE Trial $30M -0.9x 7.0x
NXL Unlock Forecast - 30 Days FREE Trial $26M -4.7x 4.4x
OM Unlock Forecast - 30 Days FREE Trial $235M -0.4x 1.5x
SMLR Unlock Forecast - 30 Days FREE Trial $317M 8.6x 0.8x
STRR Unlock Forecast - 30 Days FREE Trial $35M -1.6x 0.6x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $263M -8.4x 180.4x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $3911M 54.6x 12.3x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $40M 41.4x 32.0x

Frequently Asked Questions - IR-Med, Inc. Stock Forecast

How accurate are IR-Med, Inc. stock predictions?

Our AI model demonstrates 61% historical accuracy for IRME predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence IR-Med, Inc. stock price forecasts?

Our analysis considers IR-Med, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is IR-Med, Inc. a good investment in 2025?

Based on our AI analysis, IR-Med, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are IR-Med, Inc. forecasts updated?

IR-Med, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced IR-Med, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for IR-Med, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...